← brief for 2026-09-20 · Slowing decline

Long‐term effects of tofogliflozin on renal function in patients with type 2 diabetes: A retrospective multicenter study

Key takeaways

This study tracked people with type 2 diabetes who took a drug called tofogliflozin. It looked at how their kidney function changed over six years. It is an observational study, so it shows a link, not proof of cause. The drug is a type of diabetes medicine that may protect the kidneys.

Who did this work

N Shinagawa (Kyoto Prefectural University of Medicine) · Hiroshi Okada (Kyoto Prefectural University of Medicine) · Junya Hironaka (Kyoto Prefectural University of Medicine) · Shinta Yamamoto (Kyoto Prefectural University of Medicine) · Mari Yoneda (Kyoto Prefectural University of Medicine) · Sayaka Kawai (Kyoto Prefectural University of Medicine) · Yuto Saijo (Kyoto Prefectural University of Medicine) · Tomoya Katayama (Kyoto Prefectural University of Medicine) · Hanako Nakajima (Kyoto Prefectural University of Medicine) · Akio Kishi (Memorial Hospital) · Noriyuki Kitagawa (Kyoto University of Advanced Science) · Naoko Nakanishi (Kyoto Prefectural University of Medicine)

Source

Article · OpenAlex, Kidney disease concept sweep (verified C2778653478) · 2026-09-19
https://doi.org/10.1111/jdi.70445